Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) Revenue (2021 - 2025)

Core Scientific's Revenue history spans 5 years, with the latest figure at $79.8 million for Q4 2025.

  • For Q4 2025, Revenue fell 15.97% year-over-year to $79.8 million; the TTM value through Dec 2025 reached $319.0 million, down 37.53%, while the annual FY2025 figure was $319.0 million, 37.53% down from the prior year.
  • Revenue for Q4 2025 was $79.8 million at Core Scientific, down from $81.1 million in the prior quarter.
  • Across five years, Revenue topped out at $301.8 million in Q4 2021 and bottomed at $54.2 million in Q1 2021.
  • The 5-year median for Revenue is $116.9 million (2021), against an average of $125.8 million.
  • The largest YoY upside for Revenue was 254.9% in 2022 against a maximum downside of 59.82% in 2022.
  • A 5-year view of Revenue shows it stood at $301.8 million in 2021, then tumbled by 59.82% to $121.2 million in 2022, then rose by 17.05% to $141.9 million in 2023, then crashed by 33.12% to $94.9 million in 2024, then decreased by 15.97% to $79.8 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Revenue are $79.8 million (Q4 2025), $81.1 million (Q3 2025), and $78.6 million (Q2 2025).